An Open-label, Single-Ascending-Dose Study to Investigate the Pharmacokinetics and Safety of CONCERTA in Healthy Japanese Adult Male Subjects.
Phase of Trial: Phase I
Latest Information Update: 02 Jul 2014
At a glance
- Drugs Methylphenidate (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacokinetics
- Sponsors Janssen Research & Development
- 19 Mar 2012 Actual initiation date changed from 1 Oct 2010 to 1 Sep 2010 as reported by ClinicalTrials.gov.
- 18 Nov 2010 Actual end date changed from Oct 2010 to Nov 2010 as reported by ClinicalTrials.gov.
- 18 Nov 2010 Actual initiation date (Oct 2010) added as reported by ClinicalTrials.gov.